StocksHealthcareAVTR

AVTR

Avantor, Inc.
NYSEResearch view
Healthcare · Laboratory Analytical Instruments · Large-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$10.5B
Enterprise Value$14.1B
Income$-530.2M
Sales$6.6B
Book/sh$8.15
Cash/sh$0.54
Dividend TTM
Payout
Employees
IPO
Quick Ratio1.18
Current Ratio1.78
Debt/Eq0.71
EPS (ttm)$-0.78
EPS this Y-175.0%
EPS past 3/5Y
Sales past 3/5Y-4.5%
EPS Y/Y TTM-175.0%
Sales Y/Y TTM-3.4%
Shs Outstand682.76M
ROA-4.5%
ROE-9.5%
ROIC-3.2%
Gross Margin32.7%
Oper. Margin-3.8%
Profit Margin-8.1%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$7.4B
2021
$7.5B
2022
$7.0B
2023
$6.8B
2024
$6.6B
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%33%-4%-8%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Capital-light: capex is $128.8M against $623.8M operating cash
$623.8MOperating CF$128.8M− Capex$495.0MFree CF
COMMUNITY · $AVTR0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.